O	0	10	Prevention
O	11	13	of
B-condition	14	24	lymphedema
O	25	28	via
B-intervention	29	37	axillary
I-intervention	38	45	reverse
I-intervention	46	53	mapping
O	54	57	for
O	58	61	arm
O	62	67	lymph
O	67	68	-
O	68	72	node
O	73	85	preservation
O	86	95	following
O	96	102	breast
O	103	109	cancer
O	110	117	surgery
O	117	118	:
O	119	120	a
O	121	131	randomized
O	132	142	controlled
O	143	148	trial
O	148	149	.

O	150	156	Breast
O	157	163	cancer
O	163	164	,
O	165	169	with
O	170	172	an
O	173	182	incidence
O	183	185	of
O	186	188	32
O	188	189	%
O	189	190	,
O	191	193	is
O	194	197	the
O	198	202	most
O	203	211	frequent
O	212	218	cancer
O	219	224	among
B-ethinicity	225	233	Egyptian
O	234	239	women
O	239	240	.

O	241	244	The
O	245	254	frequency
O	255	257	of
O	258	261	arm
O	262	272	lymphedema
O	273	278	after
O	279	287	axillary
O	288	295	surgery
O	296	299	for
O	300	306	breast
O	307	313	cancer
O	314	320	ranges
O	321	325	from
O	326	327	7
O	328	330	to
O	331	333	77
O	333	334	%
O	334	335	.

O	336	344	Axillary
O	345	352	reverse
O	353	360	mapping
O	361	363	is
O	364	365	a
O	366	375	technique
O	376	381	aimed
O	382	384	to
O	385	396	distinguish
O	397	400	and
O	401	409	conserve
O	410	415	upper
O	415	416	-
O	416	420	limb
O	421	431	lymphatics
O	432	435	and
O	436	441	lymph
O	442	447	nodes
O	448	454	during
O	455	458	the
O	459	465	course
O	466	468	of
O	469	477	axillary
O	478	485	surgery
O	486	489	and
O	490	495	could
O	496	500	help
O	501	503	to
O	504	511	prevent
O	512	515	arm
O	516	526	lymphedema
O	526	527	.

O	528	536	Patients
O	537	538	(
O	538	539	n
O	540	541	=
B-total-participants	542	544	48
O	544	545	)
O	546	550	were
O	551	559	prepared
O	560	563	for
O	564	572	axillary
O	573	578	lymph
O	578	579	-
O	579	583	node
O	584	594	dissection
O	594	595	.

O	596	599	The
O	600	605	study
O	606	611	group
O	612	615	and
O	616	619	the
B-control	620	627	control
I-control	628	633	group
O	634	638	each
O	639	648	contained
B-intervention-participants	649	651	24
O	652	663	individuals
O	663	664	.

O	665	667	In
O	668	671	the
O	672	677	study
O	678	683	group
O	683	684	,
O	685	694	following
O	695	698	dye
O	699	708	injection
O	708	709	,
O	710	717	stained
O	718	721	arm
O	722	727	lymph
O	728	733	nodes
O	734	737	and
O	738	748	lymphatics
O	749	753	were
O	754	763	conserved
O	764	770	during
O	771	779	axillary
O	780	790	dissection
O	790	791	,
O	792	799	whereas
O	800	807	control
O	807	808	-
O	808	813	group
O	814	826	participants
O	827	836	underwent
O	837	840	the
O	841	853	conventional
O	854	863	procedure
O	863	864	.

O	865	868	All
O	869	881	participants
O	882	886	were
O	887	889	re
O	889	890	-
O	890	899	evaluated
O	900	905	after
O	906	907	6
O	908	914	months
O	914	915	,
O	916	919	and
O	920	923	the
O	924	933	incidence
O	934	936	of
O	937	947	lymphedema
O	948	951	was
O	952	960	recorded
O	961	963	by
O	964	973	measuring
O	974	977	arm
O	978	991	circumference
O	992	994	at
O	995	996	a
O	997	1002	level
O	1003	1005	10
O	1006	1008	cm
O	1009	1017	proximal
O	1018	1020	to
O	1021	1024	the
O	1025	1031	medial
O	1032	1042	epicondyle
O	1042	1043	.

O	1044	1047	Arm
O	1048	1058	lymphedema
O	1059	1062	was
O	1063	1070	defined
O	1071	1073	as
O	1074	1075	a
O	1076	1082	change
O	1083	1085	in
O	1086	1089	the
O	1090	1103	circumference
O	1104	1106	of
O	1107	1110	the
O	1111	1122	ipsilateral
O	1123	1128	upper
O	1129	1138	extremity
O	1139	1140	>
O	1141	1142	2
O	1143	1145	cm
O	1146	1152	during
O	1153	1156	the
O	1157	1163	follow
O	1163	1164	-
O	1164	1166	up
O	1167	1173	period
O	1173	1174	.

O	1175	1178	Age
O	1178	1179	,
O	1180	1185	tumor
O	1186	1190	size
O	1191	1194	and
O	1195	1196	N
O	1197	1202	stage
O	1203	1207	were
O	1208	1211	not
O	1212	1225	significantly
O	1226	1235	different
O	1236	1243	between
O	1244	1247	the
O	1248	1253	study
O	1254	1257	and
O	1258	1265	control
O	1266	1272	groups
O	1272	1273	.

B-outcome	1274	1279	Lymph
I-outcome	1279	1280	-
I-outcome	1280	1284	node
I-outcome	1285	1298	visualization
O	1299	1302	was
O	1303	1311	achieved
O	1312	1314	in
B-iv-bin-abs	1315	1317	20
O	1318	1330	participants
O	1331	1332	(
B-iv-bin-percent	1332	1334	83
I-iv-bin-percent	1334	1335	.
I-iv-bin-percent	1335	1336	3
I-iv-bin-percent	1336	1337	%
O	1337	1338	)
O	1339	1341	in
O	1342	1345	the
O	1346	1351	study
O	1352	1357	group
O	1357	1358	.

B-outcome	1359	1369	Suspicious
I-outcome	1370	1377	stained
I-outcome	1378	1383	lymph
I-outcome	1384	1389	nodes
O	1390	1394	were
O	1395	1405	surgically
O	1406	1413	removed
O	1414	1418	from
O	1419	1423	four
O	1424	1435	individuals
O	1436	1439	but
O	1440	1446	showed
O	1447	1449	no
O	1450	1460	metastatic
O	1461	1472	involvement
O	1472	1473	.

O	1474	1476	In
B-iv-bin-abs	1477	1479	20
O	1480	1491	individuals
O	1492	1494	in
O	1495	1498	the
O	1499	1504	study
O	1505	1510	group
O	1510	1511	,
B-outcome	1512	1514	no
I-outcome	1515	1522	stained
I-outcome	1523	1528	lymph
I-outcome	1529	1534	nodes
I-outcome	1535	1539	were
I-outcome	1540	1547	removed
O	1547	1548	.

O	1549	1552	The
B-outcome	1553	1562	incidence
I-outcome	1563	1565	of
I-outcome	1566	1576	lymphedema
O	1577	1579	in
O	1580	1583	the
O	1584	1591	control
O	1592	1597	group
O	1598	1601	was
B-cv-bin-percent	1602	1604	16
I-cv-bin-percent	1604	1605	.
I-cv-bin-percent	1605	1606	7
I-cv-bin-percent	1606	1607	%
O	1607	1608	,
O	1609	1612	and
O	1613	1616	the
O	1617	1626	incidence
O	1627	1629	in
O	1630	1633	the
O	1634	1639	study
O	1640	1645	group
O	1646	1649	was
B-iv-bin-percent	1650	1651	4
I-iv-bin-percent	1651	1652	.
I-iv-bin-percent	1652	1653	2
I-iv-bin-percent	1653	1654	%
O	1654	1655	.

O	1656	1664	Axillary
O	1665	1672	reverse
O	1673	1680	mapping
O	1681	1683	is
O	1684	1685	a
O	1686	1695	minimally
O	1696	1704	invasive
O	1705	1714	technique
O	1715	1719	that
O	1720	1723	can
O	1724	1726	be
O	1727	1736	performed
O	1737	1743	during
O	1744	1752	axillary
O	1753	1758	lymph
O	1758	1759	-
O	1759	1763	node
O	1764	1774	dissection
O	1774	1775	,
O	1776	1783	helping
O	1784	1786	to
O	1787	1794	prevent
O	1795	1798	the
O	1799	1809	subsequent
O	1810	1821	development
O	1822	1824	of
O	1825	1828	arm
O	1829	1839	lymphedema
O	1839	1840	.

O	1841	1842	#
O	1842	1853	SCURCTN3276
O	1853	1854	,
O	1855	1870	retrospectively
O	1871	1881	registered
O	1882	1884	on
O	1885	1887	11
O	1888	1893	April
O	1894	1898	2017
O	1899	1901	at
O	1902	1910	Research
O	1911	1917	Ethics
O	1918	1927	Committee
O	1928	1930	at
O	1931	1934	the
O	1935	1942	Faculty
O	1943	1945	of
O	1946	1954	medicine
O	1954	1955	-
O	1955	1959	Suez
O	1960	1965	Canal
O	1966	1976	University
O	1976	1977	.
